Investor Connect 820: TEN Capital Virtual Investor Education Series Part 3

In this episode of Investor Connect, host Hall T. Martin speaks with Barry Fella of Cranial Devices about their innovative approach to treating hydrocephalus. Barry sheds light on the significant challenges associated with the current treatment method, such as high failure rates, infections, and the need for multiple revisions throughout a patient's lifetime. Cranial Devices is developing a physiologic shunt that offers a safer, more reliable alternative by draining excess cerebrospinal fluid directly into the venous system, significantly reducing the likelihood of failures and complications. The new shunting method presents a promising advancement in medical technology, with numerous benefits for patients, surgeons, and healthcare payers alike. Barry elaborates on the device's FDA classification, ongoing animal pilot studies, and plans for human trials in South America or Australia. He also discusses the future market opportunities, particularly for older patients with normal pressure hydrocephalus, and how Cranial Devices aims to capture a considerable share of the revision market. Tune in to discover how this groundbreaking technology could transform the landscape of hydrocephalus treatment. Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let's go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https://tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact [email protected] Please follow, share, and leave a review. Music courtesy of Bensound.